October 19, 2004
Nonapprovable letter to Allergan
The FDA has issued a nonapprovable letter to Allergan for tazarotene capsules (oral tazarotene) for the treatment of psoriasis.
Amgen and Novartis enlisted Arnold Worldwide, Wavemaker, and Starcom Media Group for its Speak Your Migraine campaign.
Novocure and Glue Advertising put on a Facebook Live event promoting the cancer treatment Optune in March.
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).